Top Banner
Prognostic value of myogenic differentiation in adult soft tissue sarcomas (STS) A study of 855 cases from the French Sarcoma Group N Stock, MC Chateau, F Collin, L Guillou, A Leroux, B Marques, JJ Michels, D Ranchere, YM Robin, P Terrier, M Trassard, I Valo and JM Coindre Department of Pathology, Institut Bergonié, Bordeaux, France and Pathology subgroup, French Sarcoma Group, France
17

Genetic classification of STS

Jan 04, 2016

Download

Documents

YanK

Prognostic value of myogenic differentiation in adult soft tissue sarcomas (STS) A study of 855 cases from the French Sarcoma Group. N Stock, MC Chateau, F Collin, L Guillou, A Leroux, B Marques, JJ Michels, D Ranchere, YM Robin, P Terrier, M Trassard, I Valo and JM Coindre. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Genetic classification of STS

Prognostic value of myogenic differentiation in adult soft tissue sarcomas

(STS)A study of 855 cases from the

French Sarcoma Group

N Stock, MC Chateau, F Collin, L Guillou, A Leroux, B Marques, JJ Michels, D Ranchere, YM Robin, P Terrier, M Trassard, I Valo

and JM Coindre

Department of Pathology, Institut Bergonié, Bordeaux, France and Pathology subgroup, French Sarcoma Group, France

Page 2: Genetic classification of STS

Genetic classification of STS

• Sarcomas with recurrent translocations

• Sarcomas with oncogenic mutations

• Sarcomas with simple genetic profile

• Sarcomas with complex genetic profile

Page 3: Genetic classification of STS

Sarcomas with complex genetic profile

• Leiomyosarcomas

• Adult rhabdomyosarcomas

• Pleomorphic liposarcomas

• Myxofibrosarcomas

• Poorly-differentiated sarcomas / MFH

Page 4: Genetic classification of STS

Sarcomas with complex genetic profile

• Spindle cell / pleomorphic sarcomas

• Difficult to classify

• Prognosis and myogenic differentiation

– Fletcher et al. J Clin Oncol 2001;19:3045-50

– Deyrup et al. Cancer 2003;98:805-13

Page 5: Genetic classification of STS

French Sarcoma Group Database

• 2538 adult STS with primary event (January 2006)

• STS with translocations: 785 (27.2%)

• ALT/WDLPS and dedifferentiated LPS: 355 (12.3%)

• MPNST, angioS, chondroS, osteoS,..: 401 (13.9%)

• LMS, adult RMS, pleomorphic LPS, MFS and poorly-diff sarcomas/MFH: 1348 ( 46.7%)

Page 6: Genetic classification of STS

French Sarcoma Group DatabaseSarcomas with complex genetic profile

• LMS, adult RMS, pleomorphic LPS, MFS and poorly-diff sarcomas/MFH: 1348

• 1002 with paraffin block directly available (biopsy and/or surgery in FSG centers)

• 276 cases with frozen tissue for CGH-array and cDNA

Page 7: Genetic classification of STS

Sarcomas with complex genetic profileRe-classification - Methods

• Pathology review (1002)

• IHC on whole tissue sections (520):SMA, desmin, caldesmon, myogenin…

• IHC on TMA (482):muscular markers, keratin, S100, CD34, MDM2, CDK4,….

• Fletcher et al, J Clin Oncol 2001;19:3045-50

Page 8: Genetic classification of STS

• 1002 cases:– 928 complex genetic profile sarcomas– 74 reclassified: 27 DDLPS, 47 others

• 73 with metastasis at time of diagnosis and thus excluded for metastasis free survival study.

Sarcomas with complex genetic profileRe-classification - Results

Page 9: Genetic classification of STS

Sarcomas with complex genetic profileRe-classification - Results

Initial diagnosis (855)

• LMS: 279 (32.6%)

• Adult RMS: 23

• Pleomorphic LPS: 50

• MyxoFS: 32 (3.7%)

• MFH: 471 (55%)

Final diagnosis (855)

• LMS: 355 (41.5%)

• Adult RMS: 28

• Pleomorphic LPS: 50

• MyxoFS: 128 (15%)

• MFH: 294 (34.4%)

Page 10: Genetic classification of STS

Sarcomas with complex genetic profilePatients

• Median age: 62 (15 - 98)

• Sex: 447 M / 408 F

• Locations: extremities 601 (70.3%), trunk wall 159 (18.6%), internal trunk 69 (8.1%), head and neck 26 (3%)

• Deep tumors: 716 (83.7%)

• Median size: 8 cm (1 - 30)

• Median FU: 102 months

• Distant metastasis: 296 (34.6%)

Page 11: Genetic classification of STS

Sarcomas with complex genetic profilePredictive factors for metastasis

Univariate analysis

• Grade: 3.1x10-8

• Myogenic differentiation: 4.7x10-7

• Internal trunk location: 1.4x10-4

• Tumor depth: 2.7x10-9

• Tumor size: 4.4x10-7

Page 12: Genetic classification of STS

Metastasis-free survival

MyxoFS (n=128)

MFH (n=294)

LeiomyoS (n=355)

P = 6.4 x 10-6

Page 13: Genetic classification of STS

Myogenic sarcomas (n=383)

P = 4.3 x 10-7

Time in months

pro

bab

ility

Metastasis-free survivalMyogenic differentiation

Non-myogenic sarcomas (n=472)

Page 14: Genetic classification of STS

Metastasis-free survivalDegree of differentiation

Well D LeiomyoS (n=172)

Poorly D LeiomyoS (n=182)

MFH (n=294)

P = 0.002

Page 15: Genetic classification of STS

Sarcomas with complex genetic profilePredictive factors for metastasis

Multivariate analysis

1- Histological grade: x 4.65

2- Tumor depth: x 2.91

3- Myogenic differentiation: x 1.56

4- Internal trunk location: x1.52

Page 16: Genetic classification of STS

Complex genetic profile sarcomas excluding internal trunk n=626

Predictive factors for metastasis

Univariate analysis

• Grade: 3.2x10-5

• Myogenic differentiation: 1.6x10-5

• Tumor size: 0.03

Multivariate analysis

• Histological grade: x 3.3

• Myogenic differentiation: x 1.44

Page 17: Genetic classification of STS

Sarcomas with complex genetic profileConclusions

• Myogenic differentiation is an adverse prognostic factor

• About 30% of sarcomas with complex genetic profiles are poorly differentiated and difficult to classify

• Studies of genetic alterations should provide help for a more reproducible classification